XML 24 R37.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information (Tables)
12 Months Ended
Dec. 31, 2011
Segment Information [Abstract]  
Sales by Significant Product
The following table provides information on sales by significant product group:

($ in millions)
 
2011
  
2010
  
2009
 
Pharmaceutical packaging
 $731.1  $661.2  $637.3 
Disposable medical components
  106.9   100.0   104.6 
Laboratory and other services
  19.4   23.8   34.1 
Packaging Systems
  857.4   785.0   776.0 
Healthcare devices
  177.4   178.8   165.9 
Consumer products
  69.4   64.7   57.4 
Injection and administration systems
  59.0   55.3   42.9 
Tooling and other services
  30.9   25.3   18.8 
Delivery Systems
  336.7   324.1   285.0 
Intersegment sales elimination
  (1.8)  (4.4)  (5.3)
Net sales
 $1,192.3  $1,104.7  $1,055.7
Financial Information by Geographical Area
The following table presents sales and net property, plant and equipment, by the country in which the legal subsidiary is domiciled and assets are located:

   
Sales
  
Property, Plant and Equipment, Net
 
($ in millions)
 
2011
  
2010
  
2009
  
2011
  
2010
  
2009
 
United States
 $543.6  $528.2  $502.8  $272.6  $232.8  $242.5 
Germany
  184.1   151.5   148.3   118.1   117.8   129.9 
France
  94.2   89.0   105.3   41.3   42.4   45.9 
Other European countries
  242.7   225.6   209.3   69.9   77.2   83.2 
Other
  127.7   110.4   90.0   91.7   84.6   75.6 
   $1,192.3  $1,104.7  $1,055.7  $593.6  $554.8  $577.1 
Segment Information
The following tables provide summarized financial information for our segments:

($ in millions)
 
Packaging Systems
  
Delivery Systems
  
Corporate and Eliminations
  
Consolidated
 
2011
            
Net sales
 $857.4  $336.7  $(1.8) $1,192.3 
Operating profit
 $152.6  $9.8  $(52.8) $109.6 
Interest expense, net
  -   -   (16.9)  (16.9)
Income before income taxes
 $152.6  $9.8  $(69.7) $92.7 
Segment assets
 $843.5  $365.6  $190.0  $1,399.1 
Capital expenditures
  66.2   26.1   3.1   95.4 
Depreciation and amortization expense
  53.6   18.5   3.6   75.7 
                  
2010
                
Net sales
 $785.0  $324.1  $(4.4) $1,104.7 
Operating profit
 $139.3  $9.7  $(58.3) $90.7 
Interest expense, net
  -   -   (16.2)  (16.2)
Income before income taxes
 $139.3  $9.7  $(74.5) $74.5 
Segment assets
 $814.4  $350.6  $129.3  $1,294.3 
Capital expenditures
  48.9   16.3   5.9   71.1 
Depreciation and amortization expense
  50.7   19.0   3.5   73.2 
                  
2009
                
Net sales
 $776.0  $285.0  $(5.3) $1,055.7 
Operating profit
 $138.3  $9.9  $(50.7) $97.5 
Interest expense, net
  -   -   (14.4)  (14.4)
Income before income taxes
 $138.3  $9.9  $(65.1) $83.1 
Segment assets
 $824.7  $335.1  $111.2  $1,271.0 
Capital expenditures
  84.8   18.6   1.5   104.9 
Depreciation and amortization expense
  46.7   18.5   2.9   68.1